Fixing Stability And Other Viral Vector Challenges

While rapid cell and gene therapy advances have led to new approvals and customized patient treatments, commercializing these novel solutions creates unique challenges. Stable and standardized viral vector workflows are essential for getting these transformative treatments to patients. While there are known solutions, this expanding field requires deliberate attention around processes. Read about a collaborative problem-solving approach for viral vector production.